Fig. 1 · Structure
Documents & Downloads
4-(3-Methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid
Hypoglycaemic Drug
4-(3-Methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid is a hypoglycaemic agent that primarily acts by modulating glycemic response to oral glucose intake. This compound demonstrates significant potential in lowering blood glucose levels, making it valuable for research related to glucose metabolism and diabetes management. Its mechanism of action may involve enhancing insulin sensitivity and promoting glucose uptake in target tissues. This reagent is suitable for studies focusing on metabolic disorders and the development of therapeutic strategies for diabetes.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 60875-16-3 |
| Applications | Hypoglycaemic Drug |
| Formula | C11H10N2O3 |
| Molecular Weight | 218.21 |
| SMILES | O=C(O)C1=CC=C(N2N=C(C)CC2=O)C=C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.